AI assistant
Sending…
Twist Bioscience Corp — Director's Dealing 2026
Feb 25, 2026
31873_dirs_2026-02-25_f59e7edd-5c7b-4bd6-b9e1-049baa735ccc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2026-02-23
Reporting Person: WERNER ROBERT F. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | Common Stock | S | 1693 | $46.7098 | Disposed | 55045 | Direct |
Footnotes
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
More from Twist Bioscience Corp
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 17
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25